142 related articles for article (PubMed ID: 3328027)
1. Experimental studies on the role of alkyl lysophospholipids in autologous bone marrow transplantation.
Vogler WR; Olson AC; Okamoto S; Somberg LB; Glasser L
Lipids; 1987 Nov; 22(11):919-24. PubMed ID: 3328027
[TBL] [Abstract][Full Text] [Related]
2. Purging leukemia remission marrows with alkyl-lysophospholipids, preclinical and clinical results.
Vogler WR; Olson AC; Berdel WE; Okamoto S; Glasser L
Prog Clin Biol Res; 1990; 333():1-18; discussion 19-20. PubMed ID: 2308973
[TBL] [Abstract][Full Text] [Related]
3. Purging murine leukemic marrow with alkyl-lysophospholipids.
Glasser L; Somberg LB; Vogler WR
Blood; 1984 Dec; 64(6):1288-91. PubMed ID: 6388666
[TBL] [Abstract][Full Text] [Related]
4. Effect of cryopreservation on purging of leukemic marrow with alkyl-lysophospholipids.
Vogler WR; Somberg LB; Glasser L
Exp Hematol; 1987 May; 15(4):360-4. PubMed ID: 3569439
[TBL] [Abstract][Full Text] [Related]
5. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid.
Vogler WR; Berdel WE; Olson AC; Winton EF; Heffner LT; Gordon DS
Blood; 1992 Sep; 80(6):1423-9. PubMed ID: 1520869
[TBL] [Abstract][Full Text] [Related]
6. Purging leukemic cells from simulated human remission marrow with alkyl-lysophospholipid.
Okamoto S; Olson AC; Vogler WR; Winton EF
Blood; 1987 May; 69(5):1381-7. PubMed ID: 3471282
[TBL] [Abstract][Full Text] [Related]
7. Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.
Dulisch I; Neumann HA; Löhr GW; Andreesen R
Blut; 1985 Dec; 51(6):393-9. PubMed ID: 3865693
[TBL] [Abstract][Full Text] [Related]
8. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid.
Verdonck LF; Witteveen EO; van Heugten HG; Rozemuller E; Rijksen G
Cancer Res; 1990 Jul; 50(13):4020-5. PubMed ID: 2354451
[TBL] [Abstract][Full Text] [Related]
9. Differences in heat sensitivity between normal and acute myeloid leukemic stem cells: feasibility of hyperthermic purging of leukemic cells from autologous stem cell grafts.
Wierenga PK; Setroikromo R; Kamps G; Kampinga HH; Vellenga E
Exp Hematol; 2003 May; 31(5):421-7. PubMed ID: 12763141
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro.
Schick HD; Berdel WE; Fromm M; Fink U; Jehn U; Ulm K; Reichert A; Eibl H; Unger C; Rastetter J
Lipids; 1987 Nov; 22(11):904-10. PubMed ID: 3444383
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs.
Vogler WR
Leuk Lymphoma; 1994 Mar; 13(1-2):53-60. PubMed ID: 8025524
[TBL] [Abstract][Full Text] [Related]
12. Comparison of selective cytotoxicity of alkyl lysophospholipids.
Vogler WR; Olson AC; Okamoto S; Shoji M; Raynor RL; Kuo JF; Berdel WE; Eibl H; Hajdu J; Nomura H
Lipids; 1991 Dec; 26(12):1418-23. PubMed ID: 1819744
[TBL] [Abstract][Full Text] [Related]
13. Photoradiation models for the clinical ex vivo treatment of autologous bone marrow grafts.
Atzpodien J; Gulati SC; Strife A; Clarkson BD
Blood; 1987 Aug; 70(2):484-9. PubMed ID: 2955818
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells.
Botzler C; Ellwart J; Günther W; Eissner G; Multhoff G
Exp Hematol; 1999 Mar; 27(3):470-8. PubMed ID: 10089909
[TBL] [Abstract][Full Text] [Related]
15. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation.
Newman A; Clutterbuck RD; DeLord C; Powles RL; Catovsky D; Millar JL
J Investig Med; 1995 Jun; 43(3):269-74. PubMed ID: 7614073
[TBL] [Abstract][Full Text] [Related]
16. Purging of acute myeloid leukaemia cells from stem cell grafts by hyperthermia: enhancement of the therapeutic index by the tetrapeptide AcSDKP and the alkyl-lysophospholipid ET-18-OCH(3).
Wierenga PK; Setroikromo R; Vellenga E; Kampinga HH
Br J Haematol; 2000 Dec; 111(4):1145-52. PubMed ID: 11167754
[TBL] [Abstract][Full Text] [Related]
17. A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrow.
Vogler WR; Berdel WE; Geller RB; Brochstein JA; Beveridge RA; Dalton WS; Miller KB; Lazarus HM
Adv Exp Med Biol; 1996; 416():389-96. PubMed ID: 9131178
[TBL] [Abstract][Full Text] [Related]
18. The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells.
Yamazaki T; Sieber F
Bone Marrow Transplant; 1997 Jan; 19(2):113-9. PubMed ID: 9116607
[TBL] [Abstract][Full Text] [Related]
19. The effects of alkyl-lysophospholipids on leukemic cell lines. I. Differential action on two human leukemic cell lines, HL60 and K562.
Tidwell T; Guzman G; Vogler WR
Blood; 1981 Apr; 57(4):794-7. PubMed ID: 6937218
[TBL] [Abstract][Full Text] [Related]
20. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
